Andreae Michael H
Department of Anesthesiology, Penn State Health Milton S. Hershey Medical Center, Mail Code H187, 500 University Drive, Hershey, PA,
AJOB Neurosci. 2018;9(3):190-192. doi: 10.1080/21507740.2018.1496167. Epub 2018 Sep 20.
We consider recent research findings regarding patients' individual pain perception and phenotype, embodied in the altered neural network vulnerability, the result of connatal setup and acquired exposure, to question Dr. Gligorov's inferences. We contextualize Dr. Gligorov's discourse with concrete clinical cases embedded in obstetric anesthesia scenarios, where physicians may knowingly administer placebo pain medication and where truth-telling about pain has important immediate and long-term clinical consequences, in particular during subsequent repeated clinical encounters. Furthermore, truth-telling about pain implies acknowledging the social and economic context in which pain is treated, or more often treated. In particular minorities and indigent populations are routinely undertreated for pain due to structural or individual bias driving cruel healthcare disparities. Finally, we argue that the patients' viewpoint is lacking in this debate at present but all stakeholders' perspective are important in the discussion of truth-telling about pain.
我们认为,近期有关患者个体疼痛感知和表型的研究发现,体现在神经网络易损性的改变上,这是先天性因素和后天接触的结果,对格利戈罗夫医生的推论提出了质疑。我们将格利戈罗夫医生的论述置于产科麻醉场景中的具体临床案例背景下,在这些案例中,医生可能会有意使用安慰剂止痛药物,而关于疼痛的如实告知具有重要的即时和长期临床后果,尤其是在随后的重复临床接触中。此外,关于疼痛的如实告知意味着承认治疗疼痛所处的社会和经济背景,或者更确切地说是经常治疗疼痛的背景。特别是少数群体和贫困人群,由于导致残酷医疗差距的结构性或个人偏见,在疼痛治疗方面经常得不到充分治疗。最后,我们认为目前这场辩论中缺乏患者的观点,但在关于疼痛如实告知的讨论中,所有利益相关者的观点都很重要。